Global State of Steatotic (Fatty) Liver Disease Panel

Steatotic (fatty) liver disease is now the most common chronic liver condition worldwide—yet awareness, diagnosis, and access to care continue to lag behind its growing impact.

This panel brings together leading experts in metabolic health and liver disease to provide a clear, high-level snapshot of where the field stands today—and where it’s headed. From evolving terminology and rising global recognition to advances in diagnostics, treatment, and policy, the discussion will unpack the most important developments shaping the landscape.

Grounded in both science and lived experience, the conversation will translate complex progress into practical insights—helping attendees better understand what these changes mean for people living with steatotic liver disease today, and how we can collectively move the field forward.

MASLD Updates - Science, Therapies, and Movement

The Association of Black Gastroenterologists and Hepatologists (ABGH) return for Global Fatty Liver Day with an important discussion on 'MASLD Updates - Science, Therapies, and Movement'. Tune in to learn more about practical, accessible lifestyle changes and movement strategies that can support liver health and overall wellness - all with simple approaches that can be incorporated from the comfort of your own home.

Breaking Barriers in Diagnosis

Join Global Liver Institute and Liver Coalition of San Diego for an important discussion on early detection and diagnosis of MASH. Learn how early risk-stratification, better referral pathways, and emerging treatment options, such as FDA-approved therapies for F2/F3 fibrosis, are improving outcomes and helping patients avoid progression to cirrhosis. This educational forum highlights practical strategies for clinicians, advocates, and community leaders working to advance liver health.

Seeing Beyond the Diagnosis: Understanding and Reducing Stigma in MASLD and MASH

People living with MASLD and MASH often face stigma, misconceptions, and feelings of isolation that can affect their mental health, relationships, and access to care. In this session, we explore how stigma impacts the patient journey and discuss ways patients, healthcare professionals, and communities can help create a more supportive and compassionate environment.

Steatotic (Fatty) Liver Disease: Are you at risk?

There are many common risk factors for developing fatty liver disease, but it can be paused or reversed. Learn more in this animated video & talk to your doctor about getting screened is it right for you.

KEY TAKEAWAYS FOR CLINICAL PRACTICE

Principales conclusiones para la práctica clínica